{
    "2021-04-09": [
        [
            {
                "time": "",
                "original_text": "连锁药房优质赛道，盈利能力突飞猛进的益丰药房，还能“两年三倍”？",
                "features": {
                    "keywords": [
                        "连锁药房",
                        "益丰药房",
                        "盈利能力",
                        "两年三倍"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "零售"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【国元医药|点评】正海生物2020年年报点评：再生材料领头羊，受益于进口替代和牙科增长",
                "features": {
                    "keywords": [
                        "正海生物",
                        "再生材料",
                        "进口替代",
                        "牙科增长",
                        "年报"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}